BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4160316)

  • 1. [Investigations on the behavior of GOT in erythrocytes of newborn infants and older children].
    Künzer W; Jacobi H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 83(4):439-45. PubMed ID: 4160316
    [No Abstract]   [Full Text] [Related]  

  • 2. [The demonstration of types of acid erythrocyte phosphatase in newborn infants].
    Reimann W; Rönisch P
    Z Immunitatsforsch Allerg Klin Immunol; 1968 Nov; 136(4):383-9. PubMed ID: 4237447
    [No Abstract]   [Full Text] [Related]  

  • 3. [Red blood cell levels of acetylcholinesterase in newborn infants with hyperbilirubinemia and asphyxia].
    Mydlil V; Tomásová H; Cápová E; Cerná M
    Cesk Pediatr; 1973 Oct; 28(10):548-50. PubMed ID: 4203257
    [No Abstract]   [Full Text] [Related]  

  • 4. [Presence of an antibody agglutinating umbilical cord erythrocytes in the blood of women having given birth to a child with hemolytic disease of the newborn caused by ABO incompatibility].
    Ducos J; Ohayon E; Marty Y; Bierme S
    Nouv Rev Fr Hematol; 1966; 6(3):445-52. PubMed ID: 4225372
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of serum transaminases GOT and GPT in newborn infants with hemolytic diseases].
    Nicolini A; Pani C
    Osp Maggiore; 1965 Oct; 60(10):999-1004. PubMed ID: 5892630
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acetylcholinesterase in erythrocytes as a criterion for the indication of exchange transfusion in ABO hemolysis of newborn infants].
    Stocker F; Taminelli F; de Muralt G
    Helv Paediatr Acta; 1969 Oct; 24(5):448-57. PubMed ID: 5394098
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the staining capacity of residual protein in the blood of the newborn. I. Studies of cord blood].
    Szécsényi-Nagy L; Páll G; Lukács VF; Lukács AB
    Acta Paediatr Acad Sci Hung; 1969; 10(2):105-10. PubMed ID: 4189491
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of thermo-resistant immune antibodies active against cord erythrocytes for the diagnosis of hemolytic disease of the newborn caused by ABO incompatibility].
    Ottaviano S; Menghetti E; Mencarini L; Carapella de Luca E
    Riv Ostet Ginecol; 1969 May; 24(5):163-70. PubMed ID: 5393391
    [No Abstract]   [Full Text] [Related]  

  • 9. ABO hemolytic disease of the newborn, without hyperbilirubinemia.
    Kaplan E; Herz F; Scheye E
    Am J Hematol; 1976; 1(2):279-82. PubMed ID: 1033665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of erythrocytic acetylcholinesterase activity in the hemolytic disease of the newborn due to ABO incompatibility in relation to erythrocyte age].
    Gerlini G; Ottaviano S; Sbraccia C; Carapella E; Bonanni V
    Riv Clin Pediatr; 1968; 81(5):742-5. PubMed ID: 5754265
    [No Abstract]   [Full Text] [Related]  

  • 11. [The distribution of the Lewis blood groups in women in pregnancy, newborn infants, infants and children].
    Seki K
    Nihon Hoigaku Zasshi; 1968 Sep; 22(5):487-98. PubMed ID: 5751156
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the antigenicity of factors A and B in the newborn].
    Ducos J; Ohayon E; Marty Y
    Rev Fr Transfus; 1969; 12(1):Suppl:37-43. PubMed ID: 5393863
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the behavior of glutamic oxaloacetic transaminase (GOT) in erythrocytes of normal children and those with various forms of anemia].
    Jacobi H; Ey H; Künzer W
    Z Kinderheilkd; 1965 Oct; 94(3):239-45. PubMed ID: 5882493
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavior of erythrocytic and plasmatic neuraminic acid in newborn infants with Rh and ABO hemolytic disease].
    Ambrosioni G; Serritelli G
    Clin Pediatr (Bologna); 1968 Sep; 50(9):540-6. PubMed ID: 4973613
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of the acetylcholinesterase activity of the erythrocytes in hemolytic disease of the newborn].
    Sirchia G; Ferrone S; Milani R; Masera G
    Haematol Lat; 1966; 9(3):215-20. PubMed ID: 4966138
    [No Abstract]   [Full Text] [Related]  

  • 17. [Late damage after Rh-erythroblastosis, ABO-erythroblastosis and hyperbilirubinemia in the neonate (author's transl)].
    Weber H; Ströder J
    Klin Padiatr; 1973 Sep; 185(5):383-99. PubMed ID: 4203603
    [No Abstract]   [Full Text] [Related]  

  • 18. [Incidence of erythroblastosis in the umbilical cord blood of newborn infants with materno-fetal Rh factor incompatibility without signs of isoimmunization].
    Moscatelli P; Pantarotto F; Melevendi C
    Minerva Pediatr; 1967 Oct; 19(43):1901-2. PubMed ID: 4974603
    [No Abstract]   [Full Text] [Related]  

  • 19. [The activity of glucose-6-phosphate dehydrogenase and of transketolase in the erythrocytes in hemolytic disease of the newborn].
    Kovalev IuR
    Vopr Okhr Materin Det; 1968 Jan; 13(1):9-13. PubMed ID: 4976082
    [No Abstract]   [Full Text] [Related]  

  • 20. [Personal experience with the use of light in paraphysiological neonatal hyperbilirubinemia and hemolytic disease of the newborn due to Rh and ABO factors].
    Salvioli GP; Dallacasa P
    Minerva Pediatr; 1972 Feb; 24(3):113-23. PubMed ID: 4622393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.